| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bioage Labs, Inc. (BIOA) has 10 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. BIOA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 976.9K | $17.51M | - | |
| Other | 45.0K | $806.4K | - | |
| CFO | 25.9K | $465.0K | - | |
| Dir | 22.0K | $394.2K | - | |
| Dir | 22.0K | $394.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 27, 2024 | Enright Patrick G74 | Director | Buy | 400,000 | $18.00 | $7,200,000.00 | +30.5% | -72.0% | -74.2% |